It has been demonstrated that CD200 is highly expressed in tumors and surrounding tissues of HCC and can regulate CD4 T-cell expression as well as suppress immune function in HCC patients leading to immune tolerance (74, 75). The gene discussed is CD200; the disease is hepatocellular carcinoma.